Prarip (Cariprazine) 3mg is a prescription atypical antipsychotic capsule used under specialist supervision for schizophrenia in adolescents and manic or mixed episodes associated with bipolar I disorder in children and adolescents. Prarip (Cariprazine) 3mg contains cariprazine 3 mg and helps regulate dopamine and serotonin signalling associated with psychotic and mood symptoms.
Prarip (Cariprazine) 3mg
₨ 410
Description
Prarip (Cariprazine) 3mg is not a general sleeping, calming, or behaviour-control medicine. A qualified psychiatrist must confirm the diagnosis, review the patient’s medical history, select the appropriate dose, and monitor the treatment response.
Uses & Benefits of Prarip (Cariprazine) 3mg:
A psychiatrist may prescribe Prarip (Cariprazine) 3mg as part of a structured treatment plan for the following conditions:
- Schizophrenia in adolescents aged 13–17 years: It may help manage hallucinations, delusions, suspiciousness, disorganised thinking, agitation, reduced motivation, and impaired daily functioning.
- Bipolar I disorder in patients aged 10–17 years: It may help manage acute manic or mixed episodes involving elevated or irritable mood, racing thoughts, excessive activity, impulsive behaviour, and a reduced need for sleep.
- Ongoing psychiatric symptom management: Treatment may support emotional stability, organised thinking, social functioning, and participation in daily activities when combined with appropriate psychiatric care.
The supplied literature states that pediatric patients with schizophrenia or bipolar disorder experienced improvements in PANSS and YMRS assessment scores. However, individual responses to Prarip (Cariprazine) 3mg can vary, and regular psychiatric follow-up remains necessary.
Who Should Use This?
Prarip (Cariprazine) 3mg is intended for patients who have undergone a complete psychiatric and medical assessment.
Based on the supplied literature and current prescribing information, the relevant patient groups include:
- Adolescents aged 13–17 years diagnosed with schizophrenia.
- Children and adolescents aged 10–17 years experiencing acute manic or mixed episodes associated with bipolar I disorder.
- Adolescents aged 13–17 years with autism spectrum disorder only when a child psychiatrist has evaluated the behavioural symptoms, considers cariprazine clinically appropriate, and confirms that the proposed use is supported by locally approved prescribing information.
Prarip (Cariprazine) 3mg should not be given solely for aggression, irritability, poor sleep, school difficulties, mood changes, anxiety, or unusual behaviour without a formal diagnosis.
How to Use / Dosage:
Take Prarip (Cariprazine) 3mg exactly as prescribed by the treating psychiatrist. Cariprazine is generally taken once daily and may be administered with or without food.
According to the supplied Prarip product literature:
| Indication | Age | Literature-listed dose | Maximum dose |
|---|---|---|---|
| Schizophrenia | 13–17 years | 1.5–4.5 mg once daily | 4.5 mg/day |
| Bipolar I disorder, manic or mixed episodes | 10–17 years | 3 mg or 4.5 mg once daily | 4.5 mg/day |
| Autism spectrum disorder | 13–17 years | 3 mg once daily | 4.5 mg/day |
Price in Pakistan:
Price in Pakistan: PKR 410
The provided price of Prarip (Cariprazine) 3mg is PKR 410. Patients should confirm the pack size, current retail price, batch details, prescription requirement, and stock availability before purchasing.
Medicines should only be obtained from authorised and licensed pharmacies. Regulatory and registration information may be checked through the DRAP Registered Product Data portal. DRAP advises consumers to check the authenticity and condition of therapeutic products and consult a pharmacist when in doubt.
Precautions & Side Effects:
Before using Prarip (Cariprazine) 3mg, inform the psychiatrist about:
- All prescription and non-prescription medicines.
- Vitamins, herbal remedies, and nutritional supplements.
- Previous allergic reactions to cariprazine or other medicines.
- Diabetes or a family history of diabetes.
- High cholesterol or triglyceride levels.
- Low or high blood pressure.
- Heart disease, stroke, or blood-vessel disorders.
- Seizures or conditions that increase seizure risk.
- Low white blood cell counts.
- Movement disorders or uncontrolled body movements.
- Dehydration or difficulty regulating body temperature.
- Swallowing difficulties.
- Pregnancy, planned pregnancy, or breastfeeding.
Price in Pakistan:
Price in Pakistan: PKR 410
The provided price of Prarip (Cariprazine) 3mg is PKR 410. Patients should confirm the pack size, current retail price, batch details, prescription requirement, and stock availability before purchasing.
Medicines should only be obtained from authorised and licensed pharmacies. Regulatory and registration information may be checked through the DRAP Registered Product Data portal. DRAP advises consumers to check the authenticity and condition of therapeutic products and consult a pharmacist when in doubt.
Precautions & Side Effects:
Before using Prarip (Cariprazine) 3mg, inform the psychiatrist about:
- All prescription and non-prescription medicines.
- Vitamins, herbal remedies, and nutritional supplements.
- Previous allergic reactions to cariprazine or other medicines.
- Diabetes or a family history of diabetes.
- High cholesterol or triglyceride levels.
- Low or high blood pressure.
- Heart disease, stroke, or blood-vessel disorders.
- Seizures or conditions that increase seizure risk.
- Low white blood cell counts.
- Movement disorders or uncontrolled body movements.
- Dehydration or difficulty regulating body temperature.
- Swallowing difficulties.
- Pregnancy, planned pregnancy, or breastfeeding.
Additional information
| Generic Name | Cariprazine |
|---|
